Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells

B. Diker, Omar Janneh, R.P.G. van Heeswijk, K.F.T. Copeland

    Research output: Contribution to journalArticle

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)241-245
    JournalDrug Metabolism Letters
    Volume4
    Issue number4
    Publication statusPublished - 2010

    Bibliographical note

    The full text of this item is not available from the repository.
    The journal homepage can be found at: http://www.benthamscience.com/dml/index.htm

    Keywords

    • Protease inhibitor
    • HIV-1
    • release
    • peripheral blood
    • saquinavir
    • ritonavir
    • lopinavir
    • Therapeutic drug monitoring
    • plasma drug concentrations
    • Peripheral blood mononuclear cells
    • cell-associated drug concentrations
    • Highly active antiretroviral therapy (HAART)
    • non-nucleoside
    • lymphocytes
    • Multi-drug resistance
    • breast cancer resistance protein (BCRP)
    • lipophilicity
    • anti-coagulated
    • Octanol-Saline Partition Coefficient
    • efflux proteins
    • drug-containing bathing media

    Cite this

    Diker, B., Janneh, O., van Heeswijk, R. P. G., & Copeland, K. F. T. (2010). Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. Drug Metabolism Letters, 4(4), 241-245.

    Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. / Diker, B.; Janneh, Omar; van Heeswijk, R.P.G.; Copeland, K.F.T.

    In: Drug Metabolism Letters, Vol. 4, No. 4, 2010, p. 241-245.

    Research output: Contribution to journalArticle

    Diker, B, Janneh, O, van Heeswijk, RPG & Copeland, KFT 2010, 'Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells' Drug Metabolism Letters, vol. 4, no. 4, pp. 241-245.
    Diker B, Janneh O, van Heeswijk RPG, Copeland KFT. Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. Drug Metabolism Letters. 2010;4(4):241-245.
    Diker, B. ; Janneh, Omar ; van Heeswijk, R.P.G. ; Copeland, K.F.T. / Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. In: Drug Metabolism Letters. 2010 ; Vol. 4, No. 4. pp. 241-245.
    @article{d7ddae18545c4967beef37d4d9230d93,
    title = "Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells",
    keywords = "Protease inhibitor, HIV-1, release, peripheral blood, saquinavir, ritonavir, lopinavir, Therapeutic drug monitoring, plasma drug concentrations, Peripheral blood mononuclear cells, cell-associated drug concentrations, Highly active antiretroviral therapy (HAART), non-nucleoside, lymphocytes, Multi-drug resistance, breast cancer resistance protein (BCRP), lipophilicity, anti-coagulated, Octanol-Saline Partition Coefficient, efflux proteins, drug-containing bathing media",
    author = "B. Diker and Omar Janneh and {van Heeswijk}, R.P.G. and K.F.T. Copeland",
    note = "The full text of this item is not available from the repository. The journal homepage can be found at: http://www.benthamscience.com/dml/index.htm",
    year = "2010",
    language = "English",
    volume = "4",
    pages = "241--245",
    journal = "Drug Metabolism Letters",
    issn = "1872-3128",
    publisher = "Bentham Science Publishers",
    number = "4",

    }

    TY - JOUR

    T1 - Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells

    AU - Diker, B.

    AU - Janneh, Omar

    AU - van Heeswijk, R.P.G.

    AU - Copeland, K.F.T.

    N1 - The full text of this item is not available from the repository. The journal homepage can be found at: http://www.benthamscience.com/dml/index.htm

    PY - 2010

    Y1 - 2010

    KW - Protease inhibitor

    KW - HIV-1

    KW - release

    KW - peripheral blood

    KW - saquinavir

    KW - ritonavir

    KW - lopinavir

    KW - Therapeutic drug monitoring

    KW - plasma drug concentrations

    KW - Peripheral blood mononuclear cells

    KW - cell-associated drug concentrations

    KW - Highly active antiretroviral therapy (HAART)

    KW - non-nucleoside

    KW - lymphocytes

    KW - Multi-drug resistance

    KW - breast cancer resistance protein (BCRP)

    KW - lipophilicity

    KW - anti-coagulated

    KW - Octanol-Saline Partition Coefficient

    KW - efflux proteins

    KW - drug-containing bathing media

    M3 - Article

    VL - 4

    SP - 241

    EP - 245

    JO - Drug Metabolism Letters

    JF - Drug Metabolism Letters

    SN - 1872-3128

    IS - 4

    ER -